Palonossetrom Fresenius Kabi (Palonosetron Hydrochloride)

Palonosetron hydrochloride, the active ingredient in Palonossetrom Fresenius Kabi, is a 5-HT3 receptor antagonist presented as an intravenous solution for injection use. It is used to prevent nausea and vomiting associated with chemotherapy and surgery in adult patients. GNH USA supplies Palonossetrom Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

GNH USA supplies Palonossetrom Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Palonosetron is a selective 5‑HT3 receptor antagonist used in the management of chemotherapy‑induced and postoperative nausea and vomiting. - Chemotherapy‑induced nausea and vomiting (CINV): Provides long‑lasting protection against acute and delayed episodes. - Post‑operative nausea and vomiting (PONV): Reduces the incidence of nausea and vomiting after surgical procedures. - Radiotherapy‑induced nausea and nausea  :    …  ...  ....  …   …  … . -   … … … ...  …  … … … … … … … … … … … … …  … … … … … … … … … … … 

Common  ....